Risk of Malignancy in Patients With Psoriasis Treated With Long-Term TNF-α Inhibitor Therapy
Sign in to PracticeUpdate
Only registered members have full access to PracticeUpdate content.
Additional Info
Clinical and Experimental Dermatology
From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine.
The risk of malignancy in patients with psoriasis treated with long-term tumor necrosis factor-α inhibitor: a systematic review and meta-analysis
Clin Exp Dermatol 2024 Nov 29;[EPub Ahead of Print], WT Wu, MC Chiang, YC HuangFrom MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine.